Intravital molecular imaging of small-diameter tissue-engineered vascular grafts in mice: A feasibility study

Tissue Engineering - Part C: Methods

Volumn 16, Issue 4, 2010, Pages 597-607

  Hjortnaes, Jesper ^a   Gottlieb, Danielle ^b   Figueiredo, Jose Luiz ^a   Melero Martin, Juan ^b   Kohler, Rainer H ^a   Bischoff, Joyce ^b   Weissleder, Ralph ^a   Mayer, John E ^b   Aikawa, Elena ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD; BLOOD VESSELS; CELL CULTURE; ENDOTHELIAL CELLS; ENZYME ACTIVITY; FLUORESCENCE; GRAFTS; IMAGE ANALYSIS; LACTIC ACID; ORGANIC ACIDS; ORGANIC POLYMERS; PROTEINS; SCAFFOLDS; TISSUE;

BLOOD FLOW; CAROTID ARTERY; CELL FATES; CORD BLOOD; COREGISTERED; ENDOTHELIAL PROGENITOR CELLS; FEASIBILITY STUDIES; FLUORESCENCE MICROSCOPES; GREEN FLUORESCENT PROTEIN; HISTOPATHOLOGICAL ANALYSIS; HUMAN BONE MARROW; IN-VIVO; MESENCHYMAL STEM CELL; MOLECULAR IMAGING; MOUSE CAROTID ARTERIES; MULTISPECTRAL IMAGING; NEAR INFRARED; NUDE MICE; POLY GLYCOLIC ACID; POLY L LACTIC ACID; POST-IMPLANTATION; PROTEOLYTIC ACTIVITIES; SMALL-DIAMETER; TISSUE-ENGINEERED BLOOD VESSELS; VASCULAR GRAFTS;

STEM CELLS;

MUS; MUS MUSCULUS;

GREEN FLUORESCENT PROTEIN; LACTIC ACID; POLYGLYCOLIC ACID; POLYLACTIC ACID; POLYMER; TISSUE SCAFFOLD;

ANIMAL; ARTICLE; BLOOD VESSEL PROSTHESIS; CHEMISTRY; CYTOLOGY; DRUG EFFECT; FEASIBILITY STUDY; GENETIC TRANSFECTION; GENETICS; HUMAN; IMPLANTATION; MESENCHYMAL STEM CELL; METABOLISM; METHODOLOGY; MOLECULAR IMAGING; MOUSE; NUDE MOUSE; REPRODUCIBILITY; RETROVIRUS; TIME; TISSUE ENGINEERING;

ANIMALS; BLOOD VESSEL PROSTHESIS; FEASIBILITY STUDIES; GREEN FLUORESCENT PROTEINS; HUMANS; LACTIC ACID; MESENCHYMAL STEM CELLS; MICE; MICE, NUDE; MOLECULAR IMAGING; POLYGLYCOLIC ACID; POLYMERS; PROSTHESIS IMPLANTATION; REPRODUCIBILITY OF RESULTS; RETROVIRIDAE; TIME FACTORS; TISSUE ENGINEERING; TISSUE SCAFFOLDS; TRANSFECTION;

EID: 77954962584     PISSN: 19373384     EISSN: 19373392     Source Type: Journal    
DOI: 10.1089/ten.tec.2009.0466     Document Type: Article

References (43)

1. DeFrances, C.J., Lucas, C.A., Buie, V.C., and Golosinskiy, A. 2006 National Hospital Discharge Survey. Natl Health Stat Report 2008(5):1-20.
2. Dearani, J.A., Danielson, G.K., Puga, F.J., Schaff, H.V., Warnes, C.W., Driscoll, D.J., Schleck, C.D., and Ilstrup, D.M. Late follow-up of 1095 patients undergoing operation for complex congenital heart disease utilizing pulmonary ventricle to pulmonary artery conduits. Ann Thorac Surg 75, 399-410; discussion 410-1391, 2003.
3. L'Heureux, N., McAllister, T.N., and de la Fuente, L.M. Tissue-engineered blood vessel for adult arterial revascu-larization. N Engl J Med 357, 1451, 2007.
4. Rabkin, E., and Schoen, F.J. Cardiovascular tissue engineering. Cardiovasc Pathol 11, 305, 2002.
5. Shin'oka, T., Matsumura, G., Hibino, N., Naito, Y., Watanabe, M., Konuma, T., Sakamoto, T., Nagatsu, M., and Kurosawa, H. Midterm clinical result of tissue-engineered vascular autografts seeded with autologous bone marrow cells. J Thorac Cardiovasc Surg 129, 1330, 2005.
6. Roh, J.D., Brennan, M.P., Lopez-Soler, R.I., Fong, P.M., Goyal, A., Dardik, A., and Breuer, C.K. Construction of an autologous tissue-engineered venous conduit from bone marrow-derived vascular cells: optimization of cell harvest and seeding techniques. J Pediatr Surg 42, 198, 2007.
7. Kaushal, S., Amiel, G.E., Guleserian, K.J., Shapira, O.M., Perry, T., Sutherland, F.W., Rabkin, E., Moran, A.M., Schoen, F.J., Atala, A., Soker, S., Bischoff, J., and Mayer, J.E., Jr. Functional small-diameter neovessels created using endothelial progenitor cells expanded ex vivo. Nat Med 7, 1035, 2001.
8. Shinoka, T. Tissue engineered heart valves: autologous cell seeding on biodegradable polymer scaffold. Artif Organs 26, 402, 2002.
9. Schmidt, D., Asmis, L.M., Odermatt, B., Kelm, J., Breymann, C., Gossi, M., Genoni, M., Zund, G., and Hoerstrup, S.P. Engineered living blood vessels: functional endothelia generated from human umbilical cord-derived progenitors. Ann Thorac Surg 82, 1465-1471; discussion 1471, 2006.
10. Mirensky, T.L., and Breuer, C.K. The development of tissue-engineered grafts for reconstructive cardiothoracic surgical applications. Pediatr Res 63, 559, 2008.
11. Nelson, G.N., Mirensky, T., Brennan, M.P., Roh, J.D., Yi, T., Wang, Y., and Breuer, C.K. Functional small-diameter human tissue-engineered arterial grafts in an immunodeficient mouse model: preliminary findings. Arch Surg 143, 488, 2008.
12. Shin'oka, T., Imai, Y., and Ikada, Y. Transplantation of a tissue-engineered pulmonary artery. N Engl J Med 344, 532, 2001.
13. Jaffer, F.A., Libby, P., and Weissleder, R. Molecular imaging of cardiovascular disease. Circulation 116, 1052, 2007.
14. Sosnovik, D.E., Nahrendorf, M., and Weissleder, R. Magnetic nanoparticles for MR imaging: agents, techniques and cardiovascular applications. Basic Res Cardiol 103, 122, 2008.
15. Aikawa, E., Nahrendorf, M., Sosnovik, D., Lok, V.M., Jaffer, F.A., Aikawa, M., and Weissleder, R. Multimodality molecular imaging identifies proteolytic and osteogenic activities in early aortic valve disease. Circulation 115, 377, 2007.
16. Deguchi, J.O., Aikawa, E., Libby, P., Vachon, J.R., Inada, M., Krane, S.M., Whittaker, P., and Aikawa, M. Matrix metalloproteinase-13=collagenase-3 deletion promotes collagen accumulation and organization in mouse atherosclerotic plaques. Circulation 112, 2708, 2005.
17. Deguchi, J.O., Aikawa, M., Tung, C.H., Aikawa, E., Kim, D.E., Ntziachristos, V., Weissleder, R., and Libby, P. Inflammation in atherosclerosis: visualizing matrix metalloproteinase action in macrophages in vivo. Circulation 114, 55, 2006.
18. Jaffer, F.A., Libby, P., and Weissleder, R. Molecular and cellular imaging of atherosclerosis: emerging applications. J Am Coll Cardiol 47, 1328, 2006.
19. Nahrendorf, M., Sosnovik, D.E., and Weissleder, R. MR-optical imaging of cardiovascular molecular targets. Basic Res Cardiol 103, 87, 2008.
20. Sutherland, F.W., Perry, T.E., Yu, Y., Sherwood, M.C., Rabkin, E., Masuda, Y., Garcia, G.A., McLellan, D.L., Engelmayr, G.C., Jr., Sacks, M.S., Schoen, F.J., and Mayer, J.E., Jr. From stem cells to viable autologous semilunar heart valve. Circulation 111, 2783, 2005.
21. Sodian, R., Hoerstrup, S.P., Sperling, J.S., Daebritz, S., Martin, D.P., Moran, A.M., Kim, B.S., Schoen, F.J., Vacanti, J.P., and Mayer, J.E., Jr. Early in vivo experience with tissue-engineered trileaflet heart valves. Circulation 102(19 Suppl 3), III22, 2000.
22. Goyal, A., Wang, Y., Su, H., Dobrucki, L.W., Brennan, M., Fong, P., Dardik, A., Tellides, G., Sinusas, A., Pober, J.S., Saltzman, W.M., and Breuer, C.K. Development of a model system for preliminary evaluation of tissue-engineered vascular conduits. J Pediatr Surg 41, 787, 2006.
23. Roh, J.D., Nelson, G.N., Brennan, M.P., Mirensky, T.L., Yi, T., Hazlett, T.F., Tellides, G., Sinusas, A.J., Pober, J.S., Saltzman, W.M., Kyriakides, T.R., and Breuer, C.K. Small-diameter biodegradable scaffolds for functional vascular tissue engineering in the mouse model. Biomaterials 29, 1454, 2008.
24. Lopez-Soler, R.I., Brennan, M.P., Goyal, A., Wang, Y., Fong, P., Tellides, G., Sinusas, A., Dardik, A., and Breuer, C. Development of a mouse model for evaluation of small diameter vascular grafts. J Surg Res 139, 1, 2007.
25. Nelson, G.N., Roh, J.D., Mirensky, T.L., Wang, Y., Yi, T., Tellides, G., Pober, J.S., Shkarin, P., Shapiro, E.M., Saltzman, W.M., Papademetris, X., Fahmy, T.M., and Breuer, CK. Initial evaluation of the use of USPIO cell labeling and noninvasive MR monitoring of human tissue-engineered vascular grafts in vivo. FASEB J 22, 3888, 2008.
26. Melero-Martin, J.M., De Obaldia, M.E., Kang, S.Y., Khan, Z.A., Yuan, L., Oettgen, P., and Bischoff, J. Engineering robust and functional vascular networks in vivo with human adult and cord blood-derived progenitor cells. Circ Res 103, 194, 2008.
27. Pittenger, M.F., Mackay, A.M., Beck, S.C., Jaiswal, R.K., Douglas, R., Mosca, J.D., Moorman, M.A., Simonetti, D.W., Craig, S., and Marshak, D.R. Multilineage potential of adult human mesenchymal stem cells. Science 284, 143, 1999.
28. Kitamura, T., Onishi, M., Kinoshita, S., Shibuya, A., Miyajima, A., and Nolan, G.P. Efficient screening of retroviral cDNA expression libraries. Proc Natl Acad Sci USA 92, 9146, 1995.
29. Melero-Martin, J.M., Khan, Z.A., Picard, A., Wu, X., Par-uchuri, S., and Bischoff, J. In vivo vasculogenic potential of human blood-derived endothelial progenitor cells. Blood 109, 4761, 2007.
30. Alencar, H., Mahmood, U., Kawano, Y., Hirata, T., and Weissleder, R. Novel multiwavelength microscopic scanner for mouse imaging. Neoplasia 7, 977, 2005.
31. Hattori, H., Higuchi, K., Nogami, Y., Amano, Y., Ishihara, M., and Takase, B. A novel real-time fluorescent optical imaging system in mouse heart: a powerful tool for studying coronary circulation and cardiac function. Circulation 2, 277, 2009.
32. Aikawa, E., Nahrendorf, M., Figueiredom, J.L., Swirski, F.K., Shtatland, T., Kohler, R.H., Jaffer, F.A., Aikawa, M., and Weissleder, R. Osteogenesis associates with inflammation in early-stage atherosclerosis evaluated by molecular imaging in vivo. Circulation 116, 2841, 2007.
33. Cho, S.W., Kim, I.K., Kang, J.M., Song, K.W., Kim, H.S., Park, C.H., Yoo, K.J., and Kim, B.S. Evidence for in vivo growth potential and vascular remodeling of tissue-engineered artery. Tissue Eng 15, 901, 2009.
34. Matsumura, G., Hibino, N., Ikada, Y., Kurosawa, H., and Shin'oka, T. Successful application of tissue engineered vascular autografts: clinical experience. Biomaterials 24, 2303, 2003.
35. Matsumura, G., Ishihara, Y., Miyagawa-Tomita, S., Ikada, Y., Matsuda, S., Kurosawa, H., and Shin'oka, T. Evaluation of tissue-engineered vascular autografts. Tissue Eng 12, 3075, 2006.
36. Shin'oka, T. [Clinical results of tissue-engineered vascular autografts seeded with autologous bone marrow cells]. Nippon Geka Gakkai Zasshi 105, 459, 2004.
37. Kim, Y.S., Galis, Z.S., Rachev, A., Han, H.C., and Vito, R.P. Matrix metalloproteinase-2 and-9 are associated with high stresses predicted using a nonlinear heterogeneous model of arteries. J Biomech Eng 131, 011009, 2009.
38. Zhang, J., Nie, L., Razavian, M., Ahmed, M., Dobrucki, L.W., Asadi, A., Edwards, D.S., Azure, M., Sinusas, A.J., and Sa-deghi, M.M. Molecular imaging of activated matrix metallo-proteinases in vascular remodeling. Circulation 118, 1953, 2008.
39. Mason, D.P., Kenagy, R.D., Hasenstab, D., Bowen-Pope, D.F., Seifert, R.A., Coats, S., Hawkins, S.M., and Clowes, A.W. Matrix metalloproteinase-9 overexpression enhances vascular smooth muscle cell migration and alters remodeling in the injured rat carotid artery. Circ Res 85, 1179, 1999.
40. Johnson, C., and Galis, Z.S. Matrix metalloproteinase-2 and-9 differentially regulate smooth muscle cell migration and cell-mediated collagen organization. Arterioscler Thromb Vasc Biol 24, 54, 2004.
41. Galis, Z.S., and Khatri, J.J. Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly. Circ Res 90, 251, 2002.
42. Athanasiou, K.A., Niederauer, G.G., and Agrawal, C.M. Sterilization, toxicity, biocompatibility and clinical applications of polylactic acid=polyglycolic acid copolymers. Bio-materials 17, 93, 1996.
43. Hjortnaes, J., Bouten, C.V., Van Herwerden, L.A., Grunde-man, P.F., and Kluin, J. Translating autologous heart valve tissue engineering from bench to bed. Tissue Eng Part B Rev 15, 307, 2009.